我也是没事就拿着手机看这些信息。我看到之前美国的那个没有患疱疹的网友给我们发的有关疫苗信息中，有这样一段，Zavoico also noted that if development of vaccine and adjuvant candidates in Agenus’ pipeline
proceeds without any significant delays, unfavorable trial results, or other negative surprises, Agenus could become profitable in 2015. That is based on regulatory approvals and the launch of QS-21 for use in therapeutic cancer and chronic disease vaccines in the United States and the successful development of at least one Prophage Series of vaccines in the United States and European Union. He added that after a several year delay, he also expects a distribution partner for Oncophage to soon be identified in Russia, which will allow Agenus to start collecting revenue in 2014.
是Agenus公司CEO在2011年说的，如果一切顺利，他门的疫苗将会在2015年盈利。我好期盼啊！做梦都希望它是真的！天天也就捧着这么点希望存活了！
http://translate.google.com.hk/translate?sl=auto&tl=zh-CN&u=http%3A//www.masshightech.com/stories/2011/09/26/daily22-Agenus-advances-herpes-vaccine-in-clinic.html 
